Appropriate use of Biomarker and Genetic Testing in the Diagnosis and Management of Patients
AUAUniversity23 Marras 2022

Appropriate use of Biomarker and Genetic Testing in the Diagnosis and Management of Patients

Appropriate use of Biomarker and Genetic Testing in the Diagnosis and Management of Patients with Prostate Cancer Host: Jay D. Raman, MD, FACS Co-Hosts: Veda Giri, MD and Todd Morgan, MD CME Available: auau.auanet.org/node/37313 At the conclusion of this activity, participants will be able to 1. Assess how to maximize the benefits and minimize the harms of prostate cancer detection by carefully selecting patients and by using the necessary tools to detect clinically meaningful prostate cancer while avoiding unnecessary biopsies and detection of clinically unimportant cancers. 2. Discuss the available blood, urine and tissue biomarkers used to enhance detection of higher-grade prostate cancer, the evidence supporting their use and the clinical scenarios in which they are most valuable to be used. 3. Identify the criteria for genetic testing of prostate cancer patients, the gene panels available, and options for testing these men. 4. Utilize the results of genetic testing to improve outcomes among patients with metastatic prostate cancer, including recommendations regarding PARP-inhibition, chemotherapy and immunotherapy. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme

Jaksot(428)

Treatment Intensification in Metastatic HSPC

Treatment Intensification in Metastatic HSPC

Treatment Intensification in Metastatic HSPC CME Available: https://auau.auanet.org/node/41733 ACKNOWLEDGEMENTS: Support provided by independent educational grants from:  Lantheus Medical Imaging No...

30 Syys 202441min

Appropriate Use of Genetic Testing (who, what, when and how?)

Appropriate Use of Genetic Testing (who, what, when and how?)

Appropriate Use of Genetic Testing (who, what, when and how?) CME Available: https://auau.auanet.org/node/41734 ACKNOWLEDGEMENTS: Support provided by independent educational grants from:  Lantheus M...

27 Syys 202438min

Sequencing Of Agents

Sequencing Of Agents

Sequencing Of Agents ACKNOWLEDGEMENTS: Support provided by independent educational grants from: Lantheus Medical Imaging Novartis Pharmaceuticals Corporation LEARNING OBJECTIVES: At the conclusion ...

25 Syys 202432min

Core Curriculum: Urologic Oncology: Genetics And Genomics

Core Curriculum: Urologic Oncology: Genetics And Genomics

Urologic Oncology: Genetics And Genomics AUA Urology Core Curriculum: auau.auanet.org/core Host: Jay D. Raman, MD, FACS, FRCS(Glasg) Guest: Hong Truong, MD, MS Outline: Segment 1: Genetics 101 – H...

18 Syys 202437min

Biomarkers and Molecular Imaging for Prostate Cancer

Biomarkers and Molecular Imaging for Prostate Cancer

Biomarkers and Molecular Imaging for Prostate Cancer CME Available: https://auau.auanet.org/node/41727 ACKNOWLEDGEMENTS: Support provided by independent educational grants from:  Lantheus Medical Im...

11 Syys 202433min

Core Curriculum: Kidney Cancer & SBRT in the Management of RCC

Core Curriculum: Kidney Cancer & SBRT in the Management of RCC

Kidney Cancer & SBRT in the Management of RCC AUA Urology Core Curriculum: auau.auanet.org/core Host: Jay D. Raman, MD, FACS, FRCS(Glasg) Guest: Daniel Shapiro, MD Outline: Segment 1: History of ra...

4 Syys 202435min

Core Curriculum: Pediatric Urology: Differences of Sex Development

Core Curriculum: Pediatric Urology: Differences of Sex Development

Pediatric Urology: Differences of Sex Development AUA Urology Core Curriculum: auau.auanet.org/core Host: Jay D. Raman, MD, FACS, FRCS(Glasg) Guest: Emilie Johnson, MD, MPH, FACS, FAAP Outline: Seg...

28 Elo 202431min

AUA2024:How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients

AUA2024:How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients

How to use Prostate-Specific Membrane Antigen-Positron Emission Tomography/CT in the Management of Relapsing Prostate Cancer Patients following Local Therapy with Curative Intent CME Available: http...

21 Elo 20241h 41min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
rss-narsisti
adhd-podi
rahapuhetta
rss-rahamania
kesken
psykologia
rss-liian-kuuma-peruna
rss-niinku-asia-on
rss-eron-alkemiaa
rss-arkea-ja-aurinkoa-podcast-espanjasta
esa-saarinen-filosofia-ja-systeemiajattelu
rss-duodecim-lehti
rss-vapaudu-voimaasi
rss-luonnollinen-synnytys-podcast
rss-tietoinen-yhteys-podcast-2
rss-finnish-daily-dialogues
ihminen-tavattavissa-tommy-hellsten-instituutti